These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 149394)

  • 1. Influence of dextran 70 on the action of the primary fibrinolysis inhibitor ("alpha2-plasmin inhibitor").
    Carlin G; Saldeen T
    Thromb Res; 1978 Apr; 12(4):681-6. PubMed ID: 149394
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of dextran on fibrinolysis inhibition activity in serum.
    Carlin G; Saldeen T
    Thromb Res; 1978 Jun; 12(6):1165-75. PubMed ID: 151346
    [No Abstract]   [Full Text] [Related]  

  • 3. The behavior of alpha2-plasmin inhibitor in fibrinolytic states.
    Aoki N; Moroi M; Matsuda M; Tachiya K
    J Clin Invest; 1977 Aug; 60(2):361-9. PubMed ID: 68962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of histones and dextran on some properties of fibrin, particularly on its susceptibility to plasmin.
    Kppeć M; Wegrzynowicz Z; Zajdel M; Sawecka J; Szumiel I
    Thromb Res; 1974 Sep; 5(3):359-74. PubMed ID: 4280155
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of plasmin-mediated fibrinolysis by vitamin E.
    Moroz LA; Gilmore NJ
    Nature; 1976 Jan; 259(5540):235-7. PubMed ID: 129706
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of traditional crude drugs on fibrinolysis by plasmin: antiplasmin principles in eupolyphaga.
    Kawashiri N; Toriizuka K; Adachi I; Ueno M; Terasawa K; Horikoshi I
    Chem Pharm Bull (Tokyo); 1986 Jun; 34(6):2512-7. PubMed ID: 2945650
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of low molecular weight dextran sulphate on plasmin activity measured with S-2251.
    Matsuo O; Kawaguchi T; Kosugi T; Mihara H
    Acta Physiol Lat Am; 1980; 30(3):193-8. PubMed ID: 6180601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of heparin, plasmin, dextran and low-molecular-weight dextran on electrically induced thromboses.
    Flemma RJ; Acinapura AJ; Silver D; Anlyan WG
    Am Surg; 1966 Jan; 32(1):17-9. PubMed ID: 4221357
    [No Abstract]   [Full Text] [Related]  

  • 9. Suppressed fibrinolysis after administration of low-dose aprotinin: reduced level of plasmin-alpha2-plasmin inhibitor complexes and postoperative blood loss.
    Mastroroberto P; Chello M; Zofrea S; Marchese AR
    Eur J Cardiothorac Surg; 1995; 9(3):143-5. PubMed ID: 7540397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human plasmin enzymatic activity is inhibited by chemically modified dextrans.
    Ledoux D; Papy-Garcia D; Escartin Q; Sagot MA; Cao Y; Barritault D; Courtois J; Hornebeck W; Caruelle JP
    J Biol Chem; 2000 Sep; 275(38):29383-90. PubMed ID: 10889187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Kinetics of in vitro fibrinolysis by plasmin and a plasmin-streptokinase equimolar complex].
    Aĭsina RB; Zhitkova IuV; Eremeev NL; Popova GIu; Kazanskaia NF
    Ukr Biokhim Zh (1978); 1991; 63(1):20-6. PubMed ID: 1827551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The alpha2-plasmin inhibitor levels in liver diseases.
    Aoki N; Yamanaka T
    Clin Chim Acta; 1978 Mar; 84(1-2):99-105. PubMed ID: 76519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antithrombotic effect of dextran-40 in man is due to enhanced fibrinolysis in vivo.
    Jones CI; Payne DA; Hayes PD; Naylor AR; Bell PR; Thompson MM; Goodall AH
    J Vasc Surg; 2008 Sep; 48(3):715-22. PubMed ID: 18572351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fibrinolytic and plasmin inhibitor activities in normal subjects and patients with acute myocardial infarction (author's transl)].
    Tamura Y; Otsuka A; Sone K; Sakurai E; Ueda S; Niki T; Mori H
    Rinsho Byori; 1980 Sep; 28(9):903-6. PubMed ID: 6166776
    [No Abstract]   [Full Text] [Related]  

  • 15. Generation of fibrinolytic activity in bovine plasma by the combined effects of chloroform and dextran sulphate.
    Jenks RL; Kluft C; Astrup T
    Haemostasis; 1981; 10(2):108-18. PubMed ID: 6161866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Considerations on fibrinolysis with particular reference to a biological inhibitor of plasmin].
    Coelho MC; Tim AR
    Hospital (Rio J); 1968 Jul; 74(1):307-14. PubMed ID: 4238955
    [No Abstract]   [Full Text] [Related]  

  • 17. Determination of fast-acting plasmin inhibitor (alpha2-antiplasmin) in plasma from patients with tendency to thrombosis and increased fibrinolysis.
    Teger-Nilsson AC; Gyzander E; Myrwold H; Noppa H; Olsson R; Wallmo L
    Haemostasis; 1978; 7(2-3):155-7. PubMed ID: 149047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the lysis of fibrin formed in the presence of dextran and other macromolecules.
    Wallenbeck IA; Tangen O
    Thromb Res; 1975 Jan; 6(1):75-86. PubMed ID: 123094
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasmin inhibitor interactions. The effectiveness of alpha2-plasmin inhibitor in the presence of alpha2-macroglobulin.
    Harpel PC
    J Exp Med; 1977 Oct; 146(4):1033-40. PubMed ID: 70499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alpha2-plasmin inhibitor (alpha2PI)].
    Mimuro J
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():708-10. PubMed ID: 15658430
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.